Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease

Abstract

Even relatively modest elevation in blood pressure is an independent risk factor for ESRD. The observed relationship does not appear to be due to confounding by clinically evident baseline kidney disease.

Keywords

MedicineBlood pressureEnd stage renal diseaseRenal functionKidney diseaseInternal medicineCohortUrinalysisConfidence intervalUrologyDiseaseSurgeryUrinary system

Affiliated Institutions

University of California, San Francisco US

Related Publications

Ideal cardiovascular health score and incident end-stage renal disease in a community-based longitudinal cohort study: the Kailuan Study

Quan Han , Shou Ling Wu , Xiao Xue Liu +9 more

Objectives To investigate an association between ideal cardiovascular health metrics (CVH) and the risk of developing end-stage renal disease (ESRD). Setting Community of Kailua...

2016 BMJ Open 21 citations

Blood pressure response to potassium supplementation in normotensive adults and children.

J Z Miller , M H Weinberger , J. C. Christian

To investigate the effect on blood pressure of a modest increase in dietary potassium intake, 38 healthy, free-living families were enrolled in a study involving 4 weeks of pota...

1987 Hypertension 56 citations

Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD

Benjamin Bowe , Yan Xie , Hong Xian +2 more

Background and objectives Experimental evidence suggests a role for monocytes in the biology of kidney disease progression; however, whether monocyte count is associated with ri...

2017 Clinical Journal of the American Soci... 69 citations

Blood Pressure and End-Stage Renal Disease in Men

Michael J. Klag , Paul K. Whelton , Bryan Randall +5 more

Elevations of blood pressure are a strong independent risk factor for end-stage renal disease; interventions to prevent the disease need to emphasize the prevention and control ...

1996 New England Journal of Medicine 1644 citations

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON

Muh Geot Wong , Vlado Perkovic , John Chalmers +15 more

OBJECTIVE The Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial reported that intensive glucose control prevents end-stage...

2016 Diabetes Care 226 citations

Publication Info

Year: 2005
Type: article
Volume: 165
Issue: 8
Pages: 923-923
Citations: 469
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

469

OpenAlex

Cite This

APA Style

                            
                                
                                    Chi‐yuan Hsu, 
                                
                                    Charles E. McCulloch, 
                                
                                    Jeanne Darbinian
                                
                                et al.
                            
                            (2005). 
                            Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease. 
                            Archives of Internal Medicine
                            , 165
                            (8)
                            , 923-923.
                            https://doi.org/10.1001/archinte.165.8.923
                        

Identifiers

DOI: 10.1001/archinte.165.8.923